key: cord-0268155-j38miczh authors: Abou-Setta, A. M. title: Border closure and travel restrictions to control the spread of COVID-19: an update to a Cochrane review date: 2022-01-25 journal: nan DOI: 10.1101/2022.01.22.22269686 sha: fcd3df6f451e481b8f4a7ed2649a0f3596a6d92b doc_id: 268155 cord_uid: j38miczh Background: COVID-19 has proven to be more difficult to manage for many reasons including its high infectivity rate. One of the potential ways to limit its spread is by limiting free travel across borders, including via air travel. The objective of this systematic review is to identify, critically-appraise and summarize evidence on border closures and travel restrictions. Methods: This review is based on the Cochrane review: "International travel-related control measures to contain the COVID-19 pandemic" and followed the same methodology. In brief, we searched for clinical and modelling studies in general health and COVID-19-specific bibliographic databases. The primary outcome categories were (i) cases avoided, (ii) cases detected, and (iii) a shift in epidemic development. Secondary outcomes were other infectious disease transmission outcomes, healthcare utilisation, resource requirements and adverse effects if identified in studies assessing at least one primary outcome. Results: We included 55, mostly modelling, studies that met our inclusion criteria. Fourteen new studies were identified in the updated search, as well as updated companions (e.g., peer-reviewed publications that were previously only available as pre-prints). Most studies were of moderate to high quality. The added studies did not change the main conclusions of the Cochrane review nor the quality of the evidence (very low to low certainty). However, it did add to the evidence base for most outcomes. Conclusions: Weak evidence supports the use of border closures to limit the spread of COVID-19 from region to regions via air travel. Real-world studies are required to support these conclusions. In humans, coronaviruses may cause respiratory infections ranging from the common cold to COVID-19 has proven to be more difficult to manage, compared to previous epidemics, for many reasons including its high infectivity rate. The mean reproductive number (R0), which represents the speed of spread or transmissibility, of SARS-CoV-2 (the virus that causes has been estimated to be around 3.28, 1 which is higher than that for SARS (1.7-1.9) and MERS (<1) 2 . To combat the transmission of SARS-CoV-2, governments and public health organizations/ officials have implemented polices to decrease the disease spread including border closures and travel restrictions. A recent Cochrane review 3 showed that there was little evidence to demonstrate the effectiveness of such policies. The objective of this systematic review is to identify, critically-appraise and summarize evidence on border closures and travel restrictions to control the spread of SARS-CoV-2 transmission between countries and regions. From 4,462 unique citations, we included 55 studies that met our inclusion criteria ( Figure 1 ). In addition to the 31 studies previously identified by the Cochrane review, 3 in the updated search, we identified 14 new studies [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] that met the inclusion criteria. We included 37 modelling studies , 39, 42, 44, 45, 50 of which six studies 37, 39, 42, 44, 45, 50 were identified in the updated search. One of the newly included studies was an interrupted time series with modeling 37 and a second was a nonrandomized comparative study. 40 Neither the Cochrane review 3 nor the updated search identified any additional observational studies. None of the included modelling studies fulfilled all the quality appraisal items; all had moderate to major concerns. Sixty-six percent of the studies (n = 29) fulfilled (i.e., no to minor concerns) at least 50% of the items. The least concerns were for the items "Are the structural assumptions transparent and justified?" and "Are the input parameters transparent and justified?". The most concerns were regarding internal validation: "Has the internal validation process been described?" and "Has the model been shown to be internally valid?". The quality assessments for the included studies are summarized in Table 3 and 4, with individual study assessment for the studies identified in the updated search presented in Appendix 1. For the nonrandomized comparative study, 40 the individual quality assessment domains are presented in Table 5 . Overall, this study received 6 out of 8 stars and is considered to be of good quality. Similar to the Cochrane review, 3 we did not attempt to differentiate between a complete border closure versus travel restrictions (leading to varying degrees of difficulty in crossing borders), and instead report these in a combined intervention category. Studies reported on (1) 'cases avoided due to the measure' (n = 31), [6] [7] [8] [9] [10] [12] [13] [14] 16, [18] [19] [20] [21] [23] [24] [25] 28, 29, [32] [33] [34] [35] [36] [38] [39] [40] [41] 43, 44, 48, 49 (2) the shift in epidemic development (n = 20), 8, 10, 11, 14, 15, 17, 18, 21, 22, 26, 27, 30, 31, 36, 39, 42, 44, 46, 47, 50 (3) cases detected due to the measure (n = 4), 37, 45, 48, 50 and (4) secondary outcomes (n = 1). 19 The newly identified studies add to the body of the evidence, but do not change the conclusions of the Cochrane review; 3 usually positive direction of effect with travel restrictions/ border closures (low to very low-certainty evidence). Six new studies [38] [39] [40] 43, 44, 49 was identified in the updated search. In total, we included 18 modelling studies, 7, 9, 10, 12, 14, 16, 18, 19, 21, 25, 33, 35, 36, [38] [39] [40] 43, 44, 49 with most (n = 14) reporting fewer new cases (1.8% 10 to 97.8% 18 ) with travel restrictions; four studies 25, 33, 36, 38 reported no significant positive effect (very low-certainty evidence). Three new studies 40, 41, 48 were identified in the updated search. In total, we included 12 modelling studies, 6, 8, [12] [13] [14] 20, 23, 28, 32, 40, 41, 48 with most (n = 11) reporting decreased cases (18% 20 to 99% 12 reductions) with travel restrictions; one study 6 reported mixed results (very lowcertainty evidence). No studies were identified by the Cochrane review 3 or in the updated search. No studies were identified by the Cochrane review 3 or in the updated search. No new studies were identified in the updated search. The Cochrane review 3 identified three modelling studies 10, 14, 19 with all reporting decreased deaths (4.3% 10 to 98% 14 ) with travel restrictions (very low-certainty evidence). No new studies were identified in the updated search. The Cochrane review 3 identified three modelling studies. 24, 29, 34 Two studies 24, 34 reported decreased risk with travel restrictions; however, no direct effect estimates were reported. One study 29 reported mixed results (very low-certainty evidence); lessening restrictions led to an increased risk of importation at some airports, but a decreased risk at other airports. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 25, 2022. ; https://doi.org/10.1101/2022.01. 22.22269686 doi: medRxiv preprint No studies were identified by the Cochrane review 3 or in the updated search. This outcome is subclassified into: a. probability of eliminating the epidemic b. effective reproduction number c. time to outbreak d. risk of an outbreak e. number or proportion of cases at peak f. median time to peak g. epidemic curve peak h. epidemic growth acceleration i. exportation growth rate. No new studies were identified in the updated search. The Cochrane review 3 identified one modelling study 10 reporting mixed results (very low-certainty evidence). One new study 42 was identified in the updated search. In total, we included three modelling studies, 21, 30, 42 with most (n = 2) reporting benefit with travel restrictions; one study 30 reported mixed results (dependent on the severity of the border closures) (very low-certainty evidence). The newest-identified study 42 Five new studies 18, 39, 46, 47, 50 were identified in the updated search. In total, we included 11 modelling studies, 8, 15, 17, 18, 22, 26, 36, 39, 46, 47, 50 with most reporting benefits (e.g., <1 day 8 to 26 weeks 50 ) with travel restrictions; three studies 17,36,46 reported mixed results (very lowcertainty evidence). No new studies were identified in the updated search. The Cochrane review 3 identified two modelling studies 8, 11 with one study 8 reporting benefits (1% to 37%) with travel restrictions, while the second study 11 reported mixed results (very low-certainty evidence). No new studies were identified in the updated search. The Cochrane review 3 identified two modelling studies; 10, 17 one study 17 reported benefits with travel restrictions (0.3% to 8% at peak) and the other study 10 reported that an early implementation of border restrictions or a delayed border closure would lead to 79 (95% CI 67 to 97) and 91 (95% CI 77 to 110) daily cases at the epidemic peak, respectively (low-certainty evidence). One new study 44 was identified in the updated search. This modelling study 44 assessed the time to peak which equalled 31 days from the first death reported in each country, with a comparable mean (31.32 ± 13.94 days) (low-certainty evidence). In the multivariate analysis, border closure day was significantly associated with time to peak deaths (0.297). One new study 14 was identified in the updated search. This modelling study 14 assessed that travel restrictions will delay the epidemic curve about 50 days in time (low-certainty evidence). All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. No new studies were identified in the updated search. The Cochrane review 3 identified one modelling study 31 reporting benefits from travel restrictions (-6.05% change) (low-certainty evidence). No new studies were identified in the updated search. The Cochrane review 3 identified one modelling study 27 reporting benefits from travel restrictions (within China) (low-certainty evidence). This outcome is subclassified into: a. days at risk of transmission b. number or proportion of cases detected c. positive predictive value (PPV) d. probability of releasing an infected individual into the community. No studies were identified by the Cochrane review 3 or in the updated search. Three new modelling studies 37, 45, 50 were identified in the updated search. These studies reported mixed effects in terms of the proportion of cases detected. The first study 37 evaluated the effect of border closures in nine African countries. The ln(incidence rate+1) trends after border closure in South Africa, Nigeria, Ghana, Egypt, Kenya, and Senegal were higher compared to their control groups. In contrast, the ln(incidence rate+1) trends were lower than those of the control groups in Ethiopia, DRC, and Tunisia. These findings suggested that border closure alone was not effective in decreasing COVID-19 incidence in African countries. The second study 45 investigated the effect of international travel restrictions by difference in policy levels between the government and agent in 216 countries. It was found that earlier agent lockdowns (when compared to government lockdown policy) were associated with a more rapid acceleration in cases. In contrast, earlier government closure of the border compared to the agent was not necessarily associated with a slower acceleration of cases. These results indicated that local transmission may have a greater effect on disease burden compared to imported cases. The third study 50 No studies were identified by the Cochrane review 3 or in the updated search. One study was identified in the updated search. 48 This study investigated the effects of a travel ban for non-Hong Kong residents from overseas and testing and quarantine for those permitted to travel. The results indicated that tightening travel measures to 21-day quarantine reduced the risk of releasing infectious travellers to 0 for all examined countries or regions. This outcome is subclassified into: a. infectious disease transmission outcomes b. healthcare utilisation c. resource requirements d. adverse effects (if identified in studies assessing at least one primary outcome). No studies were identified by the Cochrane review 3 or in the updated search. No new studies were identified in the updated search. The Cochrane review 3 identified one modelling study 19 reporting benefits from travel restrictions on secondary outcomes related to healthcare utilisation. They showed that border closures alone, while beneficial, can not prevent hospitals from eventually reaching their capacity. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 25, 2022. ; https://doi.org/10.1101/2022.01. 22.22269686 doi: medRxiv preprint No studies were identified by the Cochrane review 3 or in the updated search. No studies were identified by the Cochrane review 3 or in the updated search. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. In addition to the 31 studies identified by the Cochrane review, we identified 14 additional studies, mostly modelling studies (e.g., simulated border closures), that compared the effectiveness of limiting travel as a measure to reduce the spread of COVID-19. The added studies did not change the main conclusions of the Cochrane review nor the quality of the evidence (very low to low certainty). However, it did add to the evidence base for most outcomes and provided evidence for 'reproduction number' and 'number or proportion of cases detected' that were not available in the Cochrane review 3 . Due to the nature of GRADEing the certainty of the evidence, it is unlikely that more studies will change the quality of the evidence. In conclusion, weak evidence supports the use of border closures to limit the spread of COVID-19 from region to regions. Real-world studies are required to support these conclusions. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 25, 2022. ; All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted January 25, 2022. ; Chen 2020 Chinazzi 2020 Costantino 2020 Davis 2020 cases, which is then used as an input parameter for a global transportation network model which generates probability distributions of the number of exported cases at each destination. Finally, a Galton-Watson branching process in each destination country estimates the probability of a major outbreak. * Gamma distributed incubation and infectious period based on SARSstudy. around transportation hubs. Ground and air travel mobility flows are estimated from real-world data and transmission dynamics are estimated in each subpopulation using a SEIR model. Model assumes the detection of imported cases to not be lower than 40% and travel probabilities, susceptibility and contact patterns to be homogenous. age-specific deterministic compartmental (susceptible (S), latent traced (Et), latent untraced (Eu), infectious (I), isolated (Q), recovered (R) and dead (D)) is then used to estimate transmission dynamics due to imported cases. The proportion of asymptomatic infections is assumed to be 34.6% and notified cases reflect only 10% of real infections per day. * Transmission dynamics in subpopulation assume a SLIR model. * Individuals transition between compartments through stochastic chain binomial processes. International • Description: moving Regression (MR) and Hidden Markov Model (HMM) * Data-driven approach. Framework for the realtime decomposition of infection growth curves into growth rate and acceleration and classification of stages ("lagging", "exponential", "deceleration", "stationary") which can be used to track intervention effects over time. Assumes that changes in cases per day are solely attributable to intervention. • Description: custom model based on Maximum Likelihood Methods * Daily probability that an infected person travels abroad is fitted to observed data and the distribution of incubation period is used to predict importation to other countries weighted by international flight data. Time to the first transmission event was then estimated using the distribution of the serial interval and the incubation period. was effective only for a short duration before scattered cases from the epidemic regions streamed in from other regions. Proportion of imported cases The coefficient of the abroad infection index increased from insignificant to 0.298 (95% CI: 0.120 to 0.459) on Mar 18, 2020, the day on which all new cases in China were imported. The coefficient returned to insignificant on Apr 2, reflecting the implementation of mandatory testing at customs, centralized quarantine, and a ban on the entry of foreigners and the "five one" international flight restrictions. Earlier agent lockdowns when compared to government lockdown policy was related to a more rapid acceleration in cases. In contrast, earlier government closure of border compared to agent was not necessarily associated with slower acceleration of cases. This may reflect local transmission having greater influence on burden of disease when compared to imported cases. No change/mixed effects/conflicting findings ( ) Time to outbreak Assessment of the flight reduction factor f, ranging from 0.00 (not cutting any flights) to 0.99 (cutting all flights by 99%) showed that the influence of f was rather small for a wide range of values. A significant increase in the progation time was only observed when f reached values close to 0.9. For example, the propagation time was approximately doubled with f = 0.95. This assumed that all international air transport worldwide would be reduced by 95%. Therefore, partial flight reductions were only able to postpone epidemic spread, and only for a short period of time. Based on this model, the predicted international arrival time window of a new variant in a country is less than 1 month. No change/mixed effects/conflicting findings ( ) Proportion of imported cases The total number of estimated imported cases from these eight counties or regions was 7 (95% CrI, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] under the Q14/T12 control strategy (i.e., release after 14-day quarantine with a test-negative on day 12, which was the regimen in force in Hong Kong during the study period), compared with 237 (95% CrI, 184-305) under a "no quarantine strategy", corresponding to 97% (95% CrI, 94-99%) effectiveness. Testing on-arrival could prevent an average of 40-42% of infectious travellers at the airport from mixing with the community. Positive (▲) Yang 2021 In countries that had enacted any international travel controls before their first COVID-19 case, the first peak was reached an average of 36 days (95% CI 10-61 days) later than it was in countries that did not enact controls until after their first case was reported (p<0.01). Countries that implemented their strictest international travel controls before detecting any COVID-19 cases reported their first case a median of 57 days (95% CI 14-70 days) later than countries that imposed their strongest controls after the first case was reported (p = 0.04). The average time to detection of the first case occurred 1.22 (95% CI 1.06-1.41) times later in countries that implemented any restrictions than in countries that implemented no travel restrictions. This time ratio was extended to 1.31 (95% CI 1.02-1.68) if countries implemented their strongest travel restrictions. The results of this study indicated that implementing international travel controls earlier delayed the initial epidemic peak by approximately 5 weeks. Although travel restrictions did not prevent the virus from entering most countries, delaying its introduction bought valuable time for local health systems and governments to prepare to respond to local transmission. Positive (▲) Number or proportion of cases in the community With no daily quota for inbound travelers (and no community NPIs or contact tracing), the cumulative cases during the first 60 days (95% CI) were 132,243 (41, 293) . With 50% of the historical inflow of inbound travelers (and no community NPIs or contact tracing), the cumulative cases during the first 60 days were 60,598 (18, 721) . With a daily quota of 10,000 for inbound travelers (and no community NPIs or contact tracing), the cumulative cases during the first 60 days were 5618 (1063-11,676). Positive (▲) Time to outbreak In G1 countries, even very strict border control measures (mandatory test upon arrival with isolation of positive test cases, and a 14-day home quarantine for everyone else (t=0, B=0.6) (and assuming another lockdown when identified new cases exceed 40,000 per week [~6,000 per day]) were not enough to prevent another outbreak, but only delay it for about 26 weeks (23 weeks without the home quarantine); another lockdown would be required if tighter measures were not introduced. Positive (▲) In G2 countries, given a sufficient confining domestic control policy (R<1 without the imported cases), the curve was kept flattened, provided that the imported risk was not increasing over time. If infectious free people had the same probability of traveling as healthy people, it was possible for G2 entities to open borders towards G1 and other G2 entities. In these two cases, screening and quarantine were not required to keep virus spreading in check; nevertheless, these measures significantly reduced the number of new cases. In a scenario in which two G2 entities had complete open borders toward each other and no quarantine or screening policies, both entities experienced decreasing numbers of cases, similarly to the use of a closed border policy. Both entities were also able to withstand the risk of importation and maintain a decreasing trend for the number of identified new cases and hospitalized patients over time if the number of infected people upon arrival was doubled. The same conclusion could not be drawn for a G2 entity that opened its border to a G3 entity; the effort of the G2 entity to contain the virus outbreak was jeopardized by increasing the number of imported cases from G3. Therefore, additional border control policies would be required for travelers from G3 entities. Individual measures when implemented alone may not be able to avoid another lock down within half a year if vaccines are still not widely deployed. However, the combination of pre-departure screening with test-and-isolate and/or self-quarantine may be sufficient for risk management. Even without any border controls towards multiple G2 and G3 entities (at a constant rate of 1000 imported cases per week), a G2 entity would be able to keep infections under control (albeit at a relatively high level of 14000 new cases per week or 2000 new cases per day). No change/mixed effects/conflicting findings ( ) The reproductive number of COVID-19 is higher compared to SARS coronavirus COVID-19, SARS and MERS: are they closely related? Travel-related control measures to contain the COVID-19 pandemic: a rapid review The PRISMA 2020 statement: an updated guideline for reporting systematic reviews Questionnaire to assess relevance and credibility of modeling studies for informing health care decision making: an ISPOR-AMCP-NPC Good Practice Task Force report. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research Delaying the COVID-19 epidemic in Australia: evaluating the effectiveness of international travel bans. Australian and New Zealand journal of public health How much leeway is there to relax COVID-19 control measures? Epidemics Assessing the Impact of Reduced Travel on Exportation Dynamics of Novel Coronavirus Infection (COVID-19) Estimating the effects of non-pharmaceutical interventions on the number of new infections with COVID-19 during the first epidemic wave Early intervention is the key to success in COVID-19 control Risk Assessment of Novel Coronavirus COVID-19 Outbreaks Outside China Quantitative Effects of Entry Restrictions and Travel Quarantine on the Next Wave of COVID-19: Case Studies of China and Singapore The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak The effectiveness of full and partial travel bans against COVID-19 spread in Australia for travellers from China during and after the epidemic peak in China Estimating the establishment of local transmission and the cryptic phase of the COVID-19 pandemic in the USA. medRxiv The dynamics of COVID-19 spread: evidence from Lebanon No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted A Two-Region SEIR COVID-19 Epidemic Model for the Island of Ireland. medRxiv The Effects of Border Shutdowns on the Spread of COVID-19 Modelling the impact of travel restrictions on COVID-19 cases in Hong Kong in early 2020 Should international borders reopen? The impact of travel restrictions on COVID-19 importation risk The reproduction number of COVID-19 and its correlation with public health interventions Is it safe to lift COVID-19 travel bans? The Newfoundland story Has the effectiveness of Australia's travel bans against China on the importation of COVID-19 been overestimated? Airport risk of importation and exportation of the COVID-19 pandemic How US Travel Restrictions on China Affected the Spread of COVID-19 in the United States A Method to Model Outbreaks of New Infectious Diseases with Pandemic Potential such as COVID-19. medRxiv Tracing and analysis of 288 early SARS-CoV-2 infections outside China: A modeling study Effect of internationally imported cases on internal spread of COVID-19: a mathematical modelling study Travel restrictions and SARS-CoV-2 transmission: an effective distance approach to estimate impact How Policies on Restaurants, Bars, Nightclubs, Masks, Schools, and Travel Influenced Swiss COVID-19 Reproduction Ratios. medRxiv Growth Rate and Acceleration Analysis of the COVID-19 Pandemic Reveals the Effect of Public Health Measures in Real Time Impact of international travel and border control measures on the global spread of the novel 2019 coronavirus outbreak SARS-Cov-2 trajectory predictions and scenario simulations from a global perspective: a modelling study Measuring imported case risk of COVID-19 from inbound international flights ---A case study on China COVID-19 Pandemic with Human Mobility Across Countries Country distancing increase reveals the effectiveness of travel restrictions in stopping COVID-19 transmission Evaluation of the effect of border closure on COVID-19 incidence rates across nine African countries: an interrupted time series study Investigating the first stage of the COVID-19 pandemic in Ukraine using epidemiological and genomic data. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases Modelling the effect of a border closure between Switzerland and Italy on the spatiotemporal spread of COVID-19 in Switzerland Impact of travel ban implementation on COVID-19 spread in Singapore, Taiwan, Hong Kong and South Korea during the early phase of the pandemic: a comparative study Quantifying COVID-19 importation risk in a dynamic network of domestic cities and international countries The effects of border control and quarantine measures on the spread of COVID-19 Evaluation of COVID-19 Mitigation Policies in Australia Using Generalised Space-Time Autoregressive Intervention Models Factors influencing the COVID-19 daily deaths peak across European countries. medRxiv Deep reinforcement learning approaches for global public health strategies for COVID-19 pandemic Delayed reaction towards emerging COVID-19 variants of concern: Does history repeat itself? Transportation research. Part A, Policy and practice Effectiveness of International Travel Controls for Delaying Local Outbreaks of COVID-19. Emerging infectious diseases The differential importation risks of COVID-19 from inbound travellers and the feasibility of targeted travel controls: A case study in Hong Kong. The Lancet regional health. Western Pacific Reopening International Borders without Quarantine: Contact Tracing Integrated Policy against COVID-19 Sustainable border control policy in the COVID-19 pandemic: A math modeling study Emeto 2021 No to minor concerns. To alleviate the concern about the uncertainty of incubation period and reporting delay, the authors conducted some robustness checks using a 7-day lag centered average and a 14-day lag centered average, respectively. No to minor concerns. "…assumed that infected cases could pass the border screening or move to another location only during their incubation period (referred to as exposed cases)." 3. Are the input parameters transparent and justified? No to minor concerns. "Airline passenger data were collected from the International Air Transport Association database." 4. Are the input parameters reasonable? No to minor concerns. "We collected the actual passenger data for the top 10 visiting cities leaving from Wuhan Tianhe International Airport before the lockdown of Wuhan city from 30 Dec to 20 Jan, 2020. Note that we did not have data for railroad and other forms of transport, and thus made an assumption that the total number of travelers is 4 times higher than that of air transport except for certain cities on Hainan Island that have no road connections to Wuhan. We made this assumption because that the number of train passengers is few times higher than that of airline in China (Statista, 2018) and the results from a population migration database suggested a similar ratio (The Tencent database, 2020 Population size, population density, population midyear (aged 15 to 65 years old), gross domestic product (GDP), geological information (longitude, latitude) and life expectancy from the United Nations database, Wikipedia, and official announcements through the news were used in our algorithm for the country and territory specific population characteristics and healthcare setting" 4. Are the input parameters reasonable? No to minor concerns. See above.Validation (external) 5. Has the external validation process been described? No to minor concerns.6. Has the model been shown to be externally valid? No to minor concerns. "For policy validation, we used an evaluation technique to estimate how the differences between the government and agent policies relate to accelerated infection, death and recovery cases [32, 33] . The total acceleration was calculated and derived in relation to the difference at the policy level. In general, earlier agent lockdowns when compared to government lockdown policy was related to a more rapid acceleration in cases" Validation (internal) 7. Has the internal validation process been described? Model structure 1. Are the structural assumptions transparent and justified? No to minor concerns. Susceptible-Exposed-Infectious-Recovered (SEIR) model extended onto a network structure, based on the concepts of the GLobal Epidemic and Mobility (GLEaM) Model 2. Are the structural assumptions reasonable given the overall objective, perspective and scope of the model? No to minor concerns. See above.3. Are the input parameters transparent and justified? Yes "For some countries had many fluctuations over the study period (e.g., Guyana) or experienced a much larger outbreak during the later of our study period (e.g., Argentina), which could result in rightcensoring for the first epidemic peak (i.e., no epidemic peak was observed according to the peak measurement). To validate if our results would be greatly affected by these issues, we used the reaching a certain threshold for cumulative incidence. We believe using the alternative outcome measurements could overcome the abovementioned misclassifications or right-censoring issues, although for some countries with low COVID-19 circulation it could introduce right-censoring as well" 6. Has the model been shown to be externally valid? No to minor concerns. Model structure 1. Are the structural assumptions transparent and justified? No to minor concerns. "extension to the Markov transition based SIR and SEIR models that have long been used to model epidemic spreading and control measures such as lockdowns and vaccines" 2. Are the structural assumptions reasonable given the overall objective, perspective and scope of the model? No to minor concerns. "In general, unidentified and identified infectious, and recovered individuals can either be free or isolated/quarantined. However, with our focus on reopening phases, we optimistically assume that anyone who has been identified as infectious will be isolated immediately to avoid virus spreading. Hospitalized people are also automatically isolated in the model. Assuming only people in the state of unidentified infectious and free to move can travel, only a small percentage of travelers are infectious upon arrival. This percentage, denoted by a, is mainly determined by the COVID-19 severity at the origin and the pre-travel screening policies (e.g., people must provide RNA/antibody test results prior to travel)." 3. Are the input parameters transparent and justified? No to minor concerns. "We use T = 0.91 with mandatory test for everyone upon arrival [25] . In the absence of such a test, T = 0." 4. Are the input parameters reasonable? No to minor concerns.